Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.99 USD | +2.23% |
|
+6.82% | +53.99% |
Jul. 01 | Avita Medical Names Chief Legal, Compliance Officer | MT |
Jun. 28 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 26.3 times its estimated earnings per share for the ongoing year.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advertising & Marketing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+53.99% | 2.21B | B | ||
+20.48% | 26.9B | A- | ||
+3.14% | 17.47B | B+ | ||
-0.47% | 12.5B | C- | ||
-11.86% | 10.86B | B | ||
-1.12% | 10B | A- | ||
-1.50% | 3.35B | C+ | ||
-27.91% | 3.07B | - | C- | |
+9.43% | 3.08B | C+ | ||
+6.96% | 2.78B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CRTO Stock
- Ratings Criteo S.A.